Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Pain During Percutaneous Transforaminal Endoscopic Spine Surgery
ChiCTR2600128250Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Herniated Lumbar Disk (3 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Numerical Rating Scale (NRS) pain score. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Herniated Lumbar Disk
Beyond the preview
Go deeper on ChiCTR2600128250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128250.